 | Denali Therapeutics (NASDAQ:DNLI) Shares Down 8.2%
americanbankingnews.com - January 18 at 1:50 PM |
| Comparing Achilles Therapeutics (NASDAQ:ACHL) and Denali Therapeutics (NASDAQ:DNLI)
americanbankingnews.com - January 16 at 12:18 PM |
 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Denali Therapeutics Inc. - DNLI
benzinga.com - January 13 at 8:19 PM |
 | Why Denali Therapeutics Stock Is Sinking This Week
finance.yahoo.com - January 13 at 8:19 PM |
 | FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
msn.com - January 13 at 1:34 PM |
 | Relative Strength Alert For Denali Therapeutics
nasdaq.com - January 13 at 1:34 PM |
| Denali Stock Tumbles; Why Biogen Isn't The Only Alzheimer's Play Under Pressure
finance.yahoo.com - January 13 at 1:34 PM |
 | Denali Therapeutics falls on clinical hold for Alzheimer’s candidate
seekingalpha.com - January 13 at 8:34 AM |
| Denali Therapeutics Announces FDA Clinical Hold on DNL919 Investigational New Drug (IND) Application
finance.yahoo.com - January 13 at 8:34 AM |
| Denali Therapeutics (NASDAQ:DNLI) Sets New 52-Week Low at $38.51
americanbankingnews.com - January 13 at 3:34 AM |
| Denali Therapeutics (NASDAQ:DNLI) Stock Price Down 4.3%
americanbankingnews.com - January 12 at 1:42 PM |
|
| Denali Therapeutics Inc Shares Close in on 52-Week Low - Market Mover
nasdaq.com - January 9 at 1:10 AM |
| Denali Therapeutics Inc. (NASDAQ:DNLI) CFO Sells $99,568.75 in Stock
insidertrades.com - January 7 at 7:10 PM |
| Denali Therapeutics Inc. (NASDAQ:DNLI) Insider Carole Ho Sells 2,845 Shares
americanbankingnews.com - January 7 at 7:10 PM |
| Insider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) COO Sells 2,846 Shares of Stock
americanbankingnews.com - January 7 at 7:10 PM |
| Morgan Stanley Trims Denali Therapeutics (NASDAQ:DNLI) Target Price to $91.00
americanbankingnews.com - January 7 at 3:24 PM |
| Denali Therapeutics Inc. Common Stock (DNLI)
nasdaq.com - January 7 at 9:18 AM |
 | Insider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) Director Sells 10,980 Shares of Stock
insidertrades.com - December 31 at 12:15 AM |
| Denali Therapeutics (NASDAQ:DNLI) Shares Down 4.7%
americanbankingnews.com - December 27 at 12:20 PM |
| Denali Therapeutics (NASDAQ:DNLI) Trading Down 4.7%
americanbankingnews.com - December 27 at 12:20 PM |
| Do Hedge Funds Love Denali Therapeutics Inc. (DNLI)?
finance.yahoo.com - December 17 at 7:09 PM |
 | FinancialNewsMedia.com: Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression
finanznachrichten.de - November 23 at 9:32 AM |
| Denali Therapeutics Announces Strategic Partner Takeda Exercises Option to Co-Develop and Co-Commercialize DNL593 (PTV:PGRN)
ca.finance.yahoo.com - November 17 at 8:38 AM |
| Denali (DNLI) Stock Up Despite Wider-Than-Expected Q3 Loss
finance.yahoo.com - November 8 at 2:56 PM |
| Should You Now Liquidate Your Denali Therapeutics (DNLI) Position?
finance.yahoo.com - November 8 at 2:56 PM |
| Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 4 at 9:31 PM |
| Denali Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
finance.yahoo.com - November 4 at 4:31 PM |
| Denali Therapeutics (NASDAQ:DNLI) shareholder returns have been impressive, earning 206% in 3 years
finance.yahoo.com - November 4 at 9:13 AM |
| Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 28 at 6:20 PM |
| Denali Therapeutics Insider Trades $500K In Company Stock
finance.yahoo.com - October 7 at 3:14 PM |
| Denali Therapeutics Announces Positive Clinical Results and Regulatory Progress for Development Programs in Amyotrophic Lateral Sclerosis (ALS)
finance.yahoo.com - October 7 at 8:51 AM |
| Denali Therapeutics Announces Upcoming Presentations on EIF2B Activator DNL343 and RIPK1 Inhibitor SAR443820/DNL788 at the 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting
finance.yahoo.com - September 29 at 7:00 PM |
| Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer
finance.yahoo.com - September 27 at 10:22 AM |
| Oppenheimer Says There’s Room for Over 50% Gains in These 3 Stocks
finance.yahoo.com - September 26 at 11:16 PM |
| Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS
finance.yahoo.com - September 9 at 3:54 PM |
|
| President And CEO Of Denali Therapeutics Sold $1.00 Million In Stock
benzinga.com - September 5 at 11:42 PM |
| Denali Therapeutics Inc (DNLI) President and CEO Ryan J. Watts Sold $1 million of Shares
finance.yahoo.com - September 3 at 5:18 PM |
| Denali Therapeutics Inc. (DNLI) Up 5.7% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - September 3 at 5:18 PM |
| Denali Therapeutics Inc. (NASDAQ:DNLI) Analysts Are Reducing Their Forecasts For This Year
finance.yahoo.com - August 6 at 7:38 AM |
| Is Denali Therapeutics Inc.'s (NASDAQ:DNLI) Stock Price Struggling As A Result Of Its Mixed Financials?
finance.yahoo.com - August 5 at 9:53 AM |
| Will Denali Therapeutics Inc. (DNLI) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 30 at 7:48 PM |
| Denali's Brain-Penetrant Enzyme Therapy Shows Durable Effect With CNS Impact In Hunter Syndrome
finance.yahoo.com - July 26 at 3:03 PM |
| Denali Therapeutics Stock Crashes; Why Investors Are Questioning Its Entire Pipeline
finance.yahoo.com - July 26 at 3:03 PM |
| Why Denali Therapeutics Stock Is Sinking Today
finance.yahoo.com - July 26 at 3:03 PM |
| Denali Therapeutics Announces Positive Interim Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with the Lysosomal Storage Disease Hunter Syndrome (MPS II)
finance.yahoo.com - July 25 at 1:21 PM |
| Denali Therapeutics is Now Oversold (DNLI)
nasdaq.com - July 23 at 1:50 PM |
| First Week of DNLI March 2022 Options Trading
nasdaq.com - July 16 at 6:22 PM |
| Denali Therapeutics Breaks Below 200-Day Moving Average - Notable for DNLI
nasdaq.com - July 15 at 6:00 PM |
| Denali Therapeutics to Present Interim Data from Phase 1/2 Study of ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at MPS 2021
finance.yahoo.com - July 15 at 1:00 PM |
| Where Do Hedge Funds Stand On Denali Therapeutics Inc. (DNLI)?
finance.yahoo.com - July 12 at 8:07 PM |
